Determining the Optimal Numbers of Cores Based on Tissue Microarray Antibody Assessment in Non-Small Cell Lung Cancer

Jason A. Wampfler, Marie Christine Aubry, Ping Yang, Darren L. Riehle, C. Dilara Savci-Heijink, Sumithra J Mandrekar, Wilma L. Lingle

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Tissue microarrays (TMAs) have been commonly utilized in translational research to rapidly screen numerous biomarkers in large samples. One major concern has been the adequate assessment of biomarkers affected by within-tumor heterogeneity and by molecular targets. Methods: Our study was designed to answer a fundamental question: How do researchers define the optimal cores to sample when designing a TMA study to minimize sampling bias and core artifact? We compared the staining results from a full-section tissue slide to the virtual TMA and from the actual TMA to the virtual TMA. Results: Three cores were demonstrated as optimal for markers such as TTF-1 and p53, but no optimal core number could be determined for markers such as Ki-67 due to the poor TMA representation of the entire tissue. Conclusion: We propose that before using TMAs to analyze large samples, particularly with significant withinsample heterogeneity, a preliminary investigation using a virtual TMA could help decide target markers to be tested for valid and valued results.

Original languageEnglish (US)
Pages (from-to)120-124
Number of pages5
JournalJournal of Cancer Science and Therapy
Volume3
Issue number6
DOIs
StatePublished - 2011

Fingerprint

Non-Small Cell Lung Carcinoma
Antibodies
Biomarkers
Tissue Array Analysis
Translational Medical Research
Selection Bias
Artifacts
Research Personnel
Staining and Labeling

Keywords

  • F-1
  • Immunohistochemistry tt
  • Ki-67
  • Lung cancer
  • P53
  • Tissue microarrays

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Determining the Optimal Numbers of Cores Based on Tissue Microarray Antibody Assessment in Non-Small Cell Lung Cancer. / Wampfler, Jason A.; Aubry, Marie Christine; Yang, Ping; Riehle, Darren L.; Dilara Savci-Heijink, C.; Mandrekar, Sumithra J; Lingle, Wilma L.

In: Journal of Cancer Science and Therapy, Vol. 3, No. 6, 2011, p. 120-124.

Research output: Contribution to journalArticle

Wampfler, Jason A. ; Aubry, Marie Christine ; Yang, Ping ; Riehle, Darren L. ; Dilara Savci-Heijink, C. ; Mandrekar, Sumithra J ; Lingle, Wilma L. / Determining the Optimal Numbers of Cores Based on Tissue Microarray Antibody Assessment in Non-Small Cell Lung Cancer. In: Journal of Cancer Science and Therapy. 2011 ; Vol. 3, No. 6. pp. 120-124.
@article{dc37ffb1688f48d89908d075fbf1ce4b,
title = "Determining the Optimal Numbers of Cores Based on Tissue Microarray Antibody Assessment in Non-Small Cell Lung Cancer",
abstract = "Background: Tissue microarrays (TMAs) have been commonly utilized in translational research to rapidly screen numerous biomarkers in large samples. One major concern has been the adequate assessment of biomarkers affected by within-tumor heterogeneity and by molecular targets. Methods: Our study was designed to answer a fundamental question: How do researchers define the optimal cores to sample when designing a TMA study to minimize sampling bias and core artifact? We compared the staining results from a full-section tissue slide to the virtual TMA and from the actual TMA to the virtual TMA. Results: Three cores were demonstrated as optimal for markers such as TTF-1 and p53, but no optimal core number could be determined for markers such as Ki-67 due to the poor TMA representation of the entire tissue. Conclusion: We propose that before using TMAs to analyze large samples, particularly with significant withinsample heterogeneity, a preliminary investigation using a virtual TMA could help decide target markers to be tested for valid and valued results.",
keywords = "F-1, Immunohistochemistry tt, Ki-67, Lung cancer, P53, Tissue microarrays",
author = "Wampfler, {Jason A.} and Aubry, {Marie Christine} and Ping Yang and Riehle, {Darren L.} and {Dilara Savci-Heijink}, C. and Mandrekar, {Sumithra J} and Lingle, {Wilma L.}",
year = "2011",
doi = "10.4172/1948-5956.1000072",
language = "English (US)",
volume = "3",
pages = "120--124",
journal = "Journal of Cancer Science and Therapy",
issn = "1948-5956",
publisher = "OMICS Publishing Group",
number = "6",

}

TY - JOUR

T1 - Determining the Optimal Numbers of Cores Based on Tissue Microarray Antibody Assessment in Non-Small Cell Lung Cancer

AU - Wampfler, Jason A.

AU - Aubry, Marie Christine

AU - Yang, Ping

AU - Riehle, Darren L.

AU - Dilara Savci-Heijink, C.

AU - Mandrekar, Sumithra J

AU - Lingle, Wilma L.

PY - 2011

Y1 - 2011

N2 - Background: Tissue microarrays (TMAs) have been commonly utilized in translational research to rapidly screen numerous biomarkers in large samples. One major concern has been the adequate assessment of biomarkers affected by within-tumor heterogeneity and by molecular targets. Methods: Our study was designed to answer a fundamental question: How do researchers define the optimal cores to sample when designing a TMA study to minimize sampling bias and core artifact? We compared the staining results from a full-section tissue slide to the virtual TMA and from the actual TMA to the virtual TMA. Results: Three cores were demonstrated as optimal for markers such as TTF-1 and p53, but no optimal core number could be determined for markers such as Ki-67 due to the poor TMA representation of the entire tissue. Conclusion: We propose that before using TMAs to analyze large samples, particularly with significant withinsample heterogeneity, a preliminary investigation using a virtual TMA could help decide target markers to be tested for valid and valued results.

AB - Background: Tissue microarrays (TMAs) have been commonly utilized in translational research to rapidly screen numerous biomarkers in large samples. One major concern has been the adequate assessment of biomarkers affected by within-tumor heterogeneity and by molecular targets. Methods: Our study was designed to answer a fundamental question: How do researchers define the optimal cores to sample when designing a TMA study to minimize sampling bias and core artifact? We compared the staining results from a full-section tissue slide to the virtual TMA and from the actual TMA to the virtual TMA. Results: Three cores were demonstrated as optimal for markers such as TTF-1 and p53, but no optimal core number could be determined for markers such as Ki-67 due to the poor TMA representation of the entire tissue. Conclusion: We propose that before using TMAs to analyze large samples, particularly with significant withinsample heterogeneity, a preliminary investigation using a virtual TMA could help decide target markers to be tested for valid and valued results.

KW - F-1

KW - Immunohistochemistry tt

KW - Ki-67

KW - Lung cancer

KW - P53

KW - Tissue microarrays

UR - http://www.scopus.com/inward/record.url?scp=84857075127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857075127&partnerID=8YFLogxK

U2 - 10.4172/1948-5956.1000072

DO - 10.4172/1948-5956.1000072

M3 - Article

AN - SCOPUS:84857075127

VL - 3

SP - 120

EP - 124

JO - Journal of Cancer Science and Therapy

JF - Journal of Cancer Science and Therapy

SN - 1948-5956

IS - 6

ER -